A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2015
At a glance
- Drugs MGL-3196 (Primary) ; Rosuvastatin (Primary) ; Simvastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors Madrigal Pharmaceuticals
- 07 Oct 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 14 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 10 Sep 2015 New trial record